June 3, 2020

The Niche

Knoepfler lab stem cell blog

C. Randal “Randy” Mills

3 min read

The idea of CIRM as a dedicated state stem cell agency was one of the things that got me excited about starting my time as a professor doing research on stem cells in California way back in 2005-2006 on the job hunt. Fast forwarding to today now 11 years later, CIRM is still on the cutting edge, but some major things have changed for California’s stem cell agency and as it looks to its future, the questions and challenges are different too. By analogy, …Read More

2 min read

CIRM announced today that its President and CEO, Randy Mills, is soon leaving for a new job as President of the National Marrow Donor Program/Be The Match in Minnesota. Update: Dr. Maria Millan, the CIRM Vice President of Therapeutics, will be its leader starting July 1 until a new leader is chosen. For this kind of position three years is a relatively short tenure so CIRM will need to scramble a bit to keep continuity and momentum as it searches for and ultimately puts in …Read More

9 min read

Change is in the air for the California stem cell agency, CIRM. It has a new President, Randy Mills, and CIRM is soon going to be like a new agency too. I recently did an interview with Mills that illuminates some of the big changes that are imminent. I also asked him what his favorite type of stem cell is and his view of the regenerative medicine regulatory changes in Japan relative to those here with the FDA. Paul: Going from the biotech industry …Read More

5 min read

By Jeanne Loring As the California Institute for Regenerative Medicine (CIRM) celebrates its successes on its 10th anniversary, there is coincidentally a less happy CIRM-related event. One of CIRM’s first investments in stem cell research was a network of dedicated stem cell laboratories throughout California. This program, called “shared labs” has been cancelled. The shared lab idea originated as a means for California researchers to work on human embryonic stem cells without compromising their funding from the NIH. CIRM invested a million dollars for …Read More

2 min read

The future is now. Or so goes the expression. For CIRM, it rings true today. Last year I blogged about what we might expect from the new CIRM that would evolve and take form in the future. I was particularly thinking about this coming incarnation of CIRM, which I called CIRM 2.0, as it related to post-2017 when existing Prop. 71 state funding will run out and I was making the case for additional state funding for beyond 2017 for CIRM. However, the stem …Read More